INS and steatosis: Although blocking S273 phosphorylation could be a promising therapeutic strategy to improve insulin sensitivity, this modification also affects other pathways in the organism, especially those related to steatosis and glycogen metabolism, resulting in unbalanced pancreatic hormones and liver damage.